The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-((3,5-dimethoxyphenyl)(phenyl)methyl)piperazin-1-yl)-3,3-diphenylpropan-1-one ID: ALA599016
PubChem CID: 9984183
Max Phase: Preclinical
Molecular Formula: C34H36N2O3
Molecular Weight: 520.67
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OC)cc(C(c2ccccc2)N2CCN(C(=O)CC(c3ccccc3)c3ccccc3)CC2)c1
Standard InChI: InChI=1S/C34H36N2O3/c1-38-30-22-29(23-31(24-30)39-2)34(28-16-10-5-11-17-28)36-20-18-35(19-21-36)33(37)25-32(26-12-6-3-7-13-26)27-14-8-4-9-15-27/h3-17,22-24,32,34H,18-21,25H2,1-2H3
Standard InChI Key: RPLRXHLXRQIHHQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
8.0621 -8.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0621 -9.4174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3476 -9.8299 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6331 -9.4174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6331 -8.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3476 -8.1799 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3476 -10.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6331 -11.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0621 -11.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3476 -7.3549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0621 -6.9424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6331 -6.9424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6331 -6.1174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9186 -5.7049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3476 -5.7049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9186 -4.8799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2042 -4.4674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4897 -4.8799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4897 -5.7049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2042 -6.1174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3476 -4.8799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0621 -4.4674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7765 -4.8799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7765 -5.7049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0621 -6.1174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7765 -10.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4910 -11.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4910 -11.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7765 -12.3049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0621 -11.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6331 -11.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9186 -12.3049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2042 -11.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2042 -11.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9186 -10.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9186 -13.1299 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6331 -13.5424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4897 -10.6549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4897 -9.8299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
19 20 2 0
20 14 1 0
6 10 1 0
15 21 2 0
3 4 1 0
21 22 1 0
10 11 2 0
22 23 2 0
4 5 1 0
23 24 1 0
10 12 1 0
24 25 2 0
25 15 1 0
5 6 1 0
9 26 2 0
12 13 1 0
26 27 1 0
27 28 2 0
13 14 1 0
28 29 1 0
3 7 1 0
29 30 2 0
30 9 1 0
13 15 1 0
8 31 2 0
1 2 1 0
31 32 1 0
14 16 2 0
32 33 2 0
7 8 1 0
33 34 1 0
16 17 1 0
34 35 2 0
35 8 1 0
1 6 1 0
17 18 2 0
36 37 1 0
32 36 1 0
7 9 1 0
18 19 1 0
38 39 1 0
34 38 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 520.67Molecular Weight (Monoisotopic): 520.2726AlogP: 6.16#Rotatable Bonds: 9Polar Surface Area: 42.01Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 6.53CX LogP: 6.16CX LogD: 6.10Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.27Np Likeness Score: -0.72
References 1. Pajouhesh H, Feng ZP, Ding Y, Zhang L, Pajouhesh H, Morrison JL, Belardetti F, Tringham E, Simonson E, Vanderah TW, Porreca F, Zamponi GW, Mitscher LA, Snutch TP.. (2010) Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors., 20 (4): [PMID:20117000 ] [10.1016/j.bmcl.2010.01.008 ] 2. (2004) Calcium channel inhibitors comprising benzhydril spaced from piperazine,